Pinnacle Bancorp
EW icon

Pinnacle Bancorp’s Edwards Lifesciences EW Stock Holding History

Pinnacle Bancorp’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.6K Sell
134
-46
-26% -$4.09K ﹤0.01% 713
2026
Q2 		$16.3K Buy
+180
New +$15.1K ﹤0.01% 664
2025
Q2 		– Sell
-90
Closed -$6.52K – 919
2025
Q1 		$6.52K Sell
90
-614
-87% -$43.9K ﹤0.01% 748
2024
Q4 		$52.1K Sell
704
-123
-15% -$8.61K 0.02% 416
2024
Q3 		$54.6K Hold
827
– – 0.01% 407
2024
Q2 		$76.4K Hold
827
– – 0.02% 324
2024
Q1 		$79K Sell
827
-132
-14% -$11.1K 0.02% 325
2023
Q4 		$73.1K Buy
959
+100
+12% +$6.96K 0.02% 322
2023
Q3 		$59.5K Hold
859
– – 0.02% 341
2023
Q2 		$81K Hold
859
– – 0.03% 285
2023
Q1 		$71.1K Hold
859
– – 0.03% 303
2022
Q4 		$64K Buy
859
+107
+14% +$8.25K 0.02% 304
2022
Q3 		$62K Buy
752
+51
+7% +$4.91K 0.03% 294
2022
Q2 		$67K Hold
701
– – 0.03% 281
2022
Q1 		$83K Buy
701
+110
+19% +$12.3K 0.03% 268
2021
Q4 		$77K Sell
591
-42
-7% -$4.9K 0.03% 284
2021
Q3 		$72K Sell
633
-215
-25% -$24.5K 0.03% 285
2021
Q2 		$88K Hold
848
– – 0.04% 259
2021
Q1 		$71K Hold
848
– – 0.03% 282
2020
Q4 		$77K Hold
848
– – 0.05% 267
2020
Q3 		$68K Sell
848
-553
-39% -$43.1K 0.05% 264
2020
Q2 		$97K Hold
1,401
– – 0.07% 202
2020
Q1 		$88K Buy
1,401
+123
+10% +$8.87K 0.08% 197
2019
Q4 		$99K Sell
1,278
-87
-6% -$6.79K 0.07% 211
2019
Q3 		$100K Buy
1,365
+87
+7% +$6.11K 0.06% 205
2019
Q2 		$79K Hold
1,278
– – 0.04% 237
2019
Q1 		$82K Hold
1,278
– – 0.05% 236
2018
Q4 		$65K Buy
+1,278
New +$64.7K 0.04% 247

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One North America
Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Pinnacle Bancorp's EW Position: Q3 2026 in Review

Pinnacle Bancorp reduced its Edwards Lifesciences (EW) stake by 26% in Q3 2026, selling an estimated $4.09K and leaving 134 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #713.

Pinnacle Bancorp first reported a position in EW in Q4 2018 and has held it in 28 quarters since. The position peaked at $100K in Q3 2019. 297 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Pinnacle Bancorp held 134 shares of Edwards Lifesciences worth $11.6K as of Q3 2026.
  • Pinnacle Bancorp sold 46 Edwards Lifesciences shares in Q3 2026, an estimated $4.09K.
  • Edwards Lifesciences made up ﹤0.01% of Pinnacle Bancorp's portfolio in Q3 2026, its #713 holding.
  • Pinnacle Bancorp first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 28 quarters since.
  • Pinnacle Bancorp's Edwards Lifesciences position peaked at $100K in Q3 2019.
  • 297 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Pinnacle Bancorp's 13F filing for Q3 2026, filed 21 Oct 2026.